Poole-Wilson P A, Buller N P, Lipkin D P
Cardiothoracic Institute and National Heart Hospital, London, United Kingdom.
Am J Cardiol. 1988 Sep 9;62(8):49E-52E. doi: 10.1016/s0002-9149(88)80011-0.
Regional blood flow to exercising skeletal muscle is reduced in patients who have undergone treatment for severe congestive heart failure, and is a key factor determining the limitation of exercise capacity. Recent studies have shown that the histology, contractile function and biochemistry of skeletal muscle are also abnormal. The mechanisms for both the reduced blood flow and the intrinsic abnormality of skeletal muscle are unknown. The interpretation of experimental data is complicated by different etiologies of heart failure, drug treatment, exercise protocols, the limitations of methods for the measurement of blood flow and metabolism in intact humans, and by the selection of particular groups of muscles for study that may not reflect changes in other muscles in the body.
在接受过严重充血性心力衰竭治疗的患者中,流向运动骨骼肌的局部血流减少,这是决定运动能力受限的关键因素。最近的研究表明,骨骼肌的组织学、收缩功能和生物化学也存在异常。血流减少和骨骼肌内在异常的机制尚不清楚。心力衰竭的不同病因、药物治疗、运动方案、完整人体中血流和代谢测量方法的局限性,以及选择特定的肌肉群进行研究(而这些肌肉群可能无法反映身体其他肌肉的变化),都使得实验数据的解读变得复杂。